The ASX 200 traded flat as WiseTech Global led a technology rally. Oxford Economics warns geopolitical tensions, tariffs and AI supply chain risks remain key global market drivers.
The ASX 200 edged higher on 29 June as healthcare and technology stocks rallied. Neuren Pharmaceuticals surged on EU regulatory news, while oil, the Australian dollar, RBA policy updates and Middle East tensions shaped market sentiment.
The ASX ended the week slightly lower with banking weakness, technology rotation and slowing economic growth. Here’s what moved Australian markets and what investors are watching next.
The ASX 200 slipped as Judo Capital plunged more than 40% following a profit downgrade. Falling oil prices, weaker commodities and banking weakness overshadowed stronger Australian employment data.
The ASX 200 gained 0.28% as technology stocks surged after softer Australian inflation data. WiseTech and Xero led gains while economists remain divided on the RBA’s next move.
The ASX 200 edged higher despite a Wall Street tech selloff as investors focused on upcoming inflation and jobs data. Healthcare and banks outperformed while technology and mining stocks lagged.
The ASX 200 rose 0.39% on June 10 as retail and financial stocks offset weakness in technology and mining sectors amid renewed US-Iran tensions.
The ASX 200 slipped 0.49% on June 9 as mining and banking stocks weighed on the market. Gold gained, housing sentiment weakened and Wall Street offered mixed signals.
The ASX 200 slipped on June 1, 2026, but technology stocks surged as AI adoption accelerated. Pro Medicus (ASX: PME) gained on A$44 million in US contract wins while housing market momentum softened.
The ASX 200 rose on Monday as Wall Street hit record highs and Brent crude fell below US$100, boosting miners while energy stocks declined.
The ASX 200 dropped 1.1% as rising US bond yields, Middle East tensions and inflation fears pressured mining and growth stocks across Australian markets.
The ASX 200 closed lower on May 11, 2026, after CSL plunged nearly 16% following a $6.9 billion impairment. Energy and tech stocks outperformed despite broader market weakness.
The ASX 200 traded flat as WiseTech Global led a technology rally. Oxford Economics warns geopolitical tensions, tariffs and AI supply chain risks remain key global market drivers.
The ASX 200 edged higher on 29 June as healthcare and technology stocks rallied. Neuren Pharmaceuticals surged on EU regulatory news, while oil, the Australian dollar, RBA policy updates and Middle East tensions shaped market sentiment.
The ASX ended the week slightly lower with banking weakness, technology rotation and slowing economic growth. Here’s what moved Australian markets and what investors are watching next.
The ASX 200 fell 0.95% as mining stocks dragged the market lower, while Wall Street rallied past 7,500 following the US-Iran peace agreement and easing energy prices.
Australian shares slipped as Fed Chair Kevin Warsh signalled possible interest rate hikes later in 2026. Gold rose, technology stocks fell, and investors reassessed global market risks.
The ASX 200 slipped 0.43% as investors awaited the RBA rate decision, despite record highs on Wall Street following a US-Iran ceasefire framework.
.webp&w=3840&q=75)
%252520(1).webp&w=3840&q=75)
.png&w=3840&q=75)
.png&w=3840&q=75)
%252520Strikes%252520Bonanza%25252047%252520%252520Antimony%252520at%252520Sunday%252520Creek%252520as%252520Critical%252520Minerals%252520Story%252520Gains%252520Momentum.webp&w=3840&q=75)